Gamze DİLEK
(Batı Akdeniz İhracatçılar Birliği Fiziksel Tıp ve Rehabilitasyon Hastanesi, Fiziksel Tıp ve Rehabilitasyon Anabilim Dalı, Bolu, Türkiye)
Yalkın ÇALIK
(Batı Akdeniz İhracatçılar Birliği Fiziksel Tıp ve Rehabilitasyon Hastanesi, Fiziksel Tıp ve Rehabilitasyon Anabilim Dalı, Bolu, Türkiye)
KAĞAN ÖZKUK
(Uşak Üniversitesi Tıp Fakültesi, Tıbbi Ekoloji ve Hidroklimatoloji Anabilim Dalı, Uşak, Türkiye)
Yıl: 2021Cilt: 4Sayı: 2ISSN: 2618-6454 / 2618-6454Sayfa Aralığı: 81 - 88İngilizce

67 0
Effect of vitamin D level and polypharmacy on the risk of falls in the elderly
Aim: To investigate the effects of polypharmacy and vitamin D levels on the risk of falls in the elderly.Methods: The prospective study included 201 patients (F/M: 155/46) aged 65 years and older who presentedwith nonspecific musculoskeletal pain. The demographic and laboratory data of the patients, as well as theresults of a single leg stance test (SLST), a timed up and go (TUG) test and levels of vitamin D were recorded.Results: The percentage of patients with polypharmacy is 15.9 percent and 29.4 percent used no medications.The SLST score was the lowest and the TUG test score was significantly higher in the polypharmacy group(p<0.05). Vitamin D levels were significantly higher in patients with normal SLST times than those withabnormal SLST times (p<0.05). The risk of falls was significantly higher among patients with a previoushistory of a fall (p<0.05). Polypharmacy and the female gender appeared as the most significant factorsaffecting the risk of falls (p<0.05), while vitamin D level was found to have no effect (p>0.05).Conclusion: Medical therapies for the treatment of diseases in the elderly should have a rational basis, as thismay reduce falls, particularly in the elderly population, that can have serious consequences, and may even leadto death.
DergiAraştırma MakalesiErişime Açık
  • [1]Wu TY, Chie WC, Yang RS, et al. Factors associated with falls among communitydwelling older people in Taiwan. Ann Acad Med Singap. 2013; 42(7):320-27.
  • [2]Moylan KC, Binder EF. Falls in older adults: risk assessment, management and prevention. Am J Med. 2007; 120(6):493.e1- 6.
  • [3]Richardson K, Bennett K, Kenny RA. Polypharmacy including falls riskincreasing medications and subsequent falls in community-dwelling middle-aged and older adults. Age Ageing. 2015; 44(1):90- 96.
  • [4]Baranzini F, Diurni M, Ceccon F, et al. Fallrelated injuries in a nursing home setting: is polypharmacy a risk factor? BMC Health Serv Res. 2009; 9:228.
  • [5]Hammond T, Wilson A. Polypharmacy and falls in elderly: A literatüre review. Nurs Midwifery Stud. 2013; 2(2):171-75.
  • [6]Kalyani RR, Stein B, Vliyil R, et al. Vitamin D treatment for the prevention of falls in older adults: Systematic review and metaanalysis. J Am Geriatr Soc. 2010; 58(7):1299-310.
  • [7]Ziere G, Dieleman JP, Hofman A, et al. Polypharmacy and falls in the middle age and elderly population. B J Clin Pharmacol. 2005;61(2):218-23.
  • [8]Ambrose AF, Paul G, Hausdorff JM. Risk factors for falls among older adults: A review of the literatüre. Maturitas. 2013;75(1):51-61.
  • [9]Kojima T, Akishita M, Nakamura T, el al. Association of the polypharmacy with fall risk among geriatric outpatients. Geriatr Gerontol Int. 2011;11(4):438-44.
  • [10]Zia A, Kamaruzzzaman SB, Tan MP. The consumption of two or more fallriskincreasing drugs rather than polypharmacy is associated with falls. Geriatr Gerontol Int. 2017; 17(3):436-70.
  • [11]Skalska A, Gałaś A, Grodzicki T. 25- hydroxyvitamin D and physical and cognitive performance in older people with chronic conditions. Pol Arch Med Wewn. 2012;122(4):162-69.
  • [12]Pan HH, Li CY, Chen TJ, et al. Association of polypharmacy with fall-related fractures in older Taiwanese people: age- and genderspecific analyses. BMJ Open. 2014;4(3):e004428.
  • [13]Halfon M, Phan O, Teta D. Vitamin D: a review on its effects on muscle strength, the risk of fall, and frailty. Biomed Res Int. 2015; 2015:953241.
  • [14]Romagnoli E, Pepe J, Piemonte S, et al. Management of endocrine disease: value and limitations of assessing vitamin D nutritional status and advised levels of vitamin D supplementation. Eur J Endocrinol. 2013; 169(4):59-69.
  • [15]Fried TR, O’leary J, Towle V, et al. Health outcomes associated with polypharmacy in Community Dwelling older adults: A systematic review J Am Geriatr Soc. 2014;62(12):2261-72.
  • [16]Balaban Ö, Nacır B, Erdem HR, et al. Evaluation of balance function. J PM&R Science. 2009; 12:133-39.
  • [17]Vellas BJ, Wayne SJ, Romero L, et al. Oneleg balance is an important predictor of injurious falls in older persons. J Am Geriatr. Soc. 1997;45(6):735-38.
  • [18]Dhalwani NN, Fahami R, Sathanapally H, et al. Association between polypharmacy and falls in older adults: a longitudinal study from England. BMJ Open. 2017;7-e016358.
  • [19]Laflamme L, Monárrez-Espino J, Johnell K, et al. Type, number or both? A populationbased matched case-control study on the risk of fall injuries among older people and number of medications beyond fall-inducing drugs. PloS One. 2015; 10(3):-e0123390.
  • [20]Ham AC, Swart KM, Enneman AWİ, et al. Medication-related fall incidents in an older, ambulant population: the B-PROOF study. Drugs Aging. 2014; 31(12):917-27.
  • [21]Bischoff-Ferrari HA, Giovannucci E, Willett WC, et al. Estimation of optimal serum concentrations of 25-hydroxyvitamin D for multiple health outcomes. Am J Clin Nutr. 2006;84(1):18-28.

TÜBİTAK ULAKBİM Ulusal Akademik Ağ ve Bilgi Merkezi Cahit Arf Bilgi Merkezi © 2019 Tüm Hakları Saklıdır.